Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | KDM4E | B2RXH2 | 7/20 | 0.67 |
| ▸ | TP53 | P04637 | 6/20 | 0.67 |
| ▸ | LMNA | P02545 | 5/20 | 0.67 |
| ▸ | SMN1; SMN2 | Q16637 | 5/20 | 0.67 |
| ▸ | CCR1 | P32246 | 3/20 | 0.67 |
| ▸ | CCR5 | P51681 | 3/20 | 0.67 |
| ▸ | CCR8 | P51685 | 3/20 | 0.67 |
| ▸ | TDP1 | Q9NUW8 | 3/20 | 0.67 |
| ▸ | ALOX15 | P16050 | 2/20 | 0.67 |
| ▸ | HTT | P42858 | 2/20 | 0.67 |
| ▸ | L3MBTL1 | Q9Y468 | 2/20 | 0.67 |
| ▸ | ALPL | P05186 | 1/20 | 0.67 |
| ▸ | HSP90AA1 | P07900 | 1/20 | 0.67 |
| ▸ | ALPI | P09923 | 1/20 | 0.67 |
| ▸ | ALPG | P10696 | 1/20 | 0.67 |
| ▸ | MAPK1 | P28482 | 1/20 | 0.67 |
| ▸ | POLB | P06746 | 2/20 | 0.52 |
| ▸ | CYP1A2 | P05177 | 1/20 | 0.52 |
| ▸ | METAP1 | P53582 | 1/20 | 0.52 |
| ▸ | BLM | P54132 | 1/20 | 0.52 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL13202960 | 0.90 | KDM4E (0.82) | KDM4ETP53LMNASMN1; SMN2CCR1 | |
| SCHEMBL636532 | 0.86 | KDM4E (0.56) | KDM4ETP53LMNASMN1; SMN2CCR1 | |
| SCHEMBL29389316 | 0.86 | KDM4E (0.56) | KDM4ETP53LMNASMN1; SMN2CCR1 | |
| SCHEMBL2768788 | 0.85 | KDM4E (0.56) | KDM4ETP53LMNASMN1; SMN2CCR1 | |
| SCHEMBL3320940 | 0.84 | CCR1 (0.51) | KDM4ETP53LMNASMN1; SMN2CCR1 | |
| SCHEMBL24712477 | 0.84 | KDM4E (0.78) | KDM4ETP53LMNASMN1; SMN2CCR1 | |
| SCHEMBL2256304 | 0.84 | KDM4E (0.54) | KDM4ETP53LMNASMN1; SMN2CCR1 | |
| SCHEMBL1657392 | 0.84 | KDM4E (0.78) | KDM4ETP53LMNASMN1; SMN2CCR1 | |
| SCHEMBL29391170 | 0.84 | KDM4E (0.78) | KDM4ETP53LMNASMN1; SMN2CCR1 | |
| SCHEMBL3341229 | 0.84 | KDM4E (0.54) | KDM4ETP53LMNASMN1; SMN2CCR1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 6 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-11248008-B2 | Heterocyclic compound and organic light emitting element using same | LT MATERIALS CO., LTD. (KR) | 2022-02-15 | — | — | US | disclosed |
| US-11183645-B2 | Organic thin film and method for manufacturing organic thin film, organic electroluminescence element, display device, illumination device, organic thin film solar cell, thin film transistor, and coating composition | NIPPON HOSO KYOKAI (JP) | 2021-11-23 | — | — | US | disclosed |
| CN-107710443-B | Organic thin film, method for producing organic thin film, organic electroluminescent element, display device, lighting device, organic thin film solar cell, thin film transistor, and coating composition | 日本放送协会 | 2019-12-17 | — | — | CN | disclosed |
| US-20190263834-A1 | HETEROCYCLIC COMPOUND AND ORGANIC LIGHT EMITTING ELEMENT USING SAME | HEESUNG MATERIAL LTD. (KR) | 2019-08-29 | — | — | US | disclosed |
| US-20190081239-A1 | ORGANIC THIN FILM AND METHOD FOR MANUFACTURING ORGANIC THIN FILM, ORGANIC ELECTROLUMINESCENCE ELEMENT, DISPLAY DEVICE, ILLUMINATION DEVICE, ORGANIC THIN FILM SOLAR CELL, THIN FILM TRANSISTOR, AND COATING COMPOSITION | NIPPON SHOKUBAI CO., LTD. (JP) | 2019-03-14 | — | — | US | disclosed |
| WO-2018097648-A1 | HETEROCYCLIC COMPOUND AND ORGANIC LIGHT EMITTING ELEMENT USING SAME | 희성소재(주) | 2018-05-31 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20190263834-A1 | HETEROCYCLIC COMPOUND AND ORGANIC LIGHT EMITTING ELEMENT USING SAME | CRY1, CRY2, CYP1A1 | KDM4E 3716/4885TP53 4479/4885LMNA 3579/4885 |
| US-11248008-B2 | Heterocyclic compound and organic light emitting element using same | CRY1, CRY2, CYP1A1 | KDM4E 3716/4885TP53 4479/4885LMNA 3579/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.